US Stock and Financial News

Marker Therapeutics Shares Climb Over 50% After FDA Approves IND for MT-601

By Stephen Nakrosis Shares of Marker Therapeutics Inc. were trading higher Friday, continuing momentum from the after-hours market Thursday following news…

Related Articles

Back to top button